Back
Delegates Premium Access

Efficacy and safety of semaglutide in patients with obesity-related heart failure: a meta-analysis of randomized clinical trials

Session: Effectively addressing adiposity as a cardiovascular risk factor
Topic: Obesity
Speaker: Doctor R. Gulhar (Riverside, US)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Radhika Gulhar

Riverside Community Hospital, Riverside (United States of America)
1 follower

6 more presentations in this session

Exercise limitations in heart failure with preserved ejection fraction and obesity: is the issue the engine or chassis?

Speaker: Doctor S. Foulkes (Edmonton, CA)

Access
Abstract
Slides
Like
Thumbnail

Long-term effect of intensive lifestyle intervention among obese arab women: a cohort study

Speaker: Associate Professor O. Kalter-Leibovici (Ramat Gan, IL)

Access
Abstract
Slides
Like
Thumbnail

My worst nightmare: obesity and hypertension

Speaker: Ms K. Liu (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Not a light matter: obesity diagnosis rates among obese hospitalized patients

Speaker: Doctor I. Avivi (Tel Aviv, IL)

Access
Abstract
Slides
Like
Thumbnail

PreveCardio program: from research to practice, impact on obesity, overweight, Mediterranean diet adherence, and physical activity patterns in a European population

Speaker: Doctor J. Flores Soler (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Effectively addressing adiposity as a cardiovascular risk factor

Speakers: Doctor R. Gulhar, Doctor S. Foulkes, Associate Professor O. Kalter-Leibovici, Ms K. Liu, Doctor I. Avivi...
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources